🔱 Intended Use: For research and laboratory purposes only. Not for human consumption, medical, or veterinary use.

🧬 What is Tirzepatide?

Tirzepatide is a once-weekly injectable medication developed by Eli Lilly. It’s a first-in-class dual GIP/GLP-1 receptor agonist, meaning it activates two incretin hormone pathways involved in appetite, digestion, and insulin regulation.

🎯 What It’s Used For
1. Type 2 Diabetes (as Mounjaro)

Approved to:
•💙 Improve blood sugar control
•📉 Reduce A1C often by 2% or more
•⚖️ Promote weight loss as an additional benefit

2. Chronic Weight Management (as Zepbound)

Approved for adults with:
BMI ≥30, or
BMI ≥27 with a weight-related condition
Clinical trials showed average weight loss of 15–22% of total body weight, depending on dose.

⚙️ How It Works
Tirzepatide mimics GIP and GLP-1, hormones that:
•🍽️ Reduce appetite
•🕒 Slow stomach emptying
•🔧 Improve insulin sensitivity
•⬇️ Decrease glucagon

These combined effects produce stronger metabolic improvements than GLP-1 alone.

💉 Dosage & Administration
Given once weekly via a disposable injection pen
Typical dose escalation: 2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg
Slow titration helps reduce side effects

⚠️ Common Side Effects
Mostly gastrointestinal:
•🤢 Nausea
•💩 Diarrhea or constipation
•🍽️ Reduced appetite
•🤮 Occasional vomiting

Less common:
😴 Fatigue
💠 Injection-site reactions

Serious but rare:
•🔥 Pancreatitis
•🫙 Gallbladder issues
•🩸 Low blood sugar (mainly with insulin or sulfonylureas)

Upgrade your experience with our premium pen kit!
Each set comes complete with:
•💉 12 high-quality needles for smooth, reliable use
•🎉 12 alcohol swabs to ensure optimal cleanliness
•🔥 A sleek metal case for protection and portability
•🔵 Blue pen, offered in 40 mg options to suit your needs